These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Resistance to treatment of Plasmodium falciparum in Central Africa]. Morales Rodríguez CM; Brito Llano L; Díaz Domínguez MA; Martínez Echevarría X; Fortún Prieto A; Montano Díaz MA Rev Cubana Med Trop; 1988; 40(1):101-4. PubMed ID: 3045909 [No Abstract] [Full Text] [Related]
4. [Current antimalarial drugs: resistance and new strategies]. Ringwald P Bull Acad Natl Med; 2007 Oct; 191(7):1273-84; discussion 1284. PubMed ID: 18447049 [TBL] [Abstract][Full Text] [Related]
5. In vitro strategies for circumventing antimalarial drug resistance. Milhous WK; Gerena L; Kyle DE; Oduola AM Prog Clin Biol Res; 1989; 313():61-72. PubMed ID: 2675118 [No Abstract] [Full Text] [Related]
6. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo. Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in malaria research: parasite biology, chemotherapy and host/parasite relationships. Trigg PI Ann Ist Super Sanita; 1985; 21(3):271-90. PubMed ID: 3914847 [No Abstract] [Full Text] [Related]
8. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax]. Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948 [TBL] [Abstract][Full Text] [Related]
9. Helicases - feasible antimalarial drug target for Plasmodium falciparum. Tuteja R FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956 [TBL] [Abstract][Full Text] [Related]
10. Screening of Coptis teeta Wall. for antimalarial effect: a preliminary report. Sharma SK; Satyanarayana S; Yadav RN; Dutta LP Indian J Malariol; 1993 Sep; 30(3):179-81. PubMed ID: 8131885 [No Abstract] [Full Text] [Related]
11. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346 [TBL] [Abstract][Full Text] [Related]
12. [Determination of the chemosensitivity of Plasmodium falciparum: methodology and interpretation]. Le Bras J; Savel J Ann Pediatr (Paris); 1987 May; 34(5):349-56. PubMed ID: 3304096 [No Abstract] [Full Text] [Related]
13. Prevention and treatment of malaria. Houghton DL Aust Fam Physician; 1985 Jan; 14(1):22-6. PubMed ID: 3885928 [No Abstract] [Full Text] [Related]
14. The origins of antimalarial drug resistance. Hastings IM Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702 [TBL] [Abstract][Full Text] [Related]
15. Antimalarial activity of some Colombian medicinal plants. Garavito G; Rincón J; Arteaga L; Hata Y; Bourdy G; Gimenez A; Pinzón R; Deharo E J Ethnopharmacol; 2006 Oct; 107(3):460-2. PubMed ID: 16713157 [TBL] [Abstract][Full Text] [Related]
19. Treatment of falciparum malaria with a single dose of mefloquine. Ponnampalam JT Singapore Med J; 1985 Apr; 26(2):207-10. PubMed ID: 3898397 [No Abstract] [Full Text] [Related]
20. [Urgent problems of the treatment and pharmacologic prevention of malaria]. Kotłowski A Wiad Parazytol; 1988; 34(4-6):503-7. PubMed ID: 3071914 [No Abstract] [Full Text] [Related] [Next] [New Search]